Dr. Roxana B. Kerns
EPO PATENT GRANT NOTICE
Amarastesia celebrates another milestone with a written notification from the EPO on the patentability of cerA&Mvix. While filing a...
top of page
Dr. Roxana B. Kerns
Oct 260 min read
4 views0 comments
Dr. Roxana B. Kerns
Oct 261 min read
Dr. Roxana Belciu Kerns selected amongst AMWC 2023, MONACO Finalists
Dr. Roxana Belciu Kerns, Aesthetic Physician with over 15 years of experience as Expert Injector and Medical Director of Orchid...
5 views0 comments
Dr. Roxana B. Kerns
Oct 261 min read
Amarastesia and Dr. Roxana Belciu Kerns is pleased to announce our collaboration with HUMAN ANATOMY LABORATORY of RUSH UNIVERSITY MEDICAL CENTER
In the light of cadaveric testing for cerA&Mvix, Amarastesia has partnered with the Human Anatomy Laboratory of RUSH UNIVERSITY MEDICAL...
6 views0 comments
Dr. Roxana B. Kerns
Oct 261 min read
Dr. Roxana Belciu Kerns and Amarastesia are thrilled to announce that we have been selected as a spoke for the ARPA-H investor catalyst Hub network.08/2024
https://www.linkedin.com/posts/amarastesia_arpah-arpaneth-medtech-activity-7252779864410251264-wSoS?utm_source=share&utm_medium=member_de...
2 views0 comments
Dr. Roxana B. Kerns
Oct 261 min read
AMARASTESIA to partner with HE-ARC UNIVERSITY OF NEWCHATEL
Through a project sponsored by INNOCHEQUE and INNOSUISSE, Amarastesia is partnering with the engineering department of HE-ARC University,...
2 views0 comments
Dr. Roxana B. Kerns
Oct 261 min read
AMARASTESIA and cerA&Mvix have been awarded a grant for medtech coaching by Innosuisse, SWITZERLAND 08/2024.
AMARASTESIA's innovative approach has been recognized and its being supported by Innosuisse with a grant for ongoing coaching and...
0 views0 comments
Dr. Roxana B. Kerns
Oct 261 min read
cerA&Mvix obtains proof of concept and validates its intended use in preclinical research and testing on animal tissue models. 10/2024, VA USA.
https://www.linkedin.com/posts/amarastesia_amarastesia-and-ceramvix-a-game-changer-activity-7253796870353784833-jPbt?utm_source=share&utm...
1 view0 comments
Dr. Roxana B. Kerns
Oct 261 min read
AMARASTESIA selected amongst three top Medtech Startups by DayOne Accelerator, Switzerland
https://www.linkedin.com/posts/dayone-healthcare-innovation_innovateinbasel-dayone-shapingthefutureofhealth-activity-7244722323927232513-...
1 view0 comments
Dr. Roxana B. Kerns
Oct 261 min read
cerA&Mvix obtains FREEDOM TO OPERATE, 08/2024
A prior art search was completed to assess the likelihood that the disposable cervical dilator might encounter freedom to operate issues....
4 views0 comments
Dr. Roxana B. Kerns
Oct 260 min read
2 views0 comments
Dr. Roxana B. Kerns
Oct 261 min read
PATENT GRANTED, February 2024
Disposable pass through dilator and method of use: US-11904122-B1 A disposable medical device, cervical dilator to dilate free of trauma...
3 views0 comments
Dr. Roxana B. Kerns
Oct 251 min read
cerA&Mvix a SAFE & FAST cervical dilatation
CerA&Mvix, developed by Amarastesia, is pioneering the concept of Safe Instrument Passageway and essential Direct Visualization within an...
0 views0 comments
bottom of page